Severe Preeclampsia Clinical Trial
The purpose of this study, to investigate whether severity of preeclampsia is associated with altered levels of heavy metals (Cd, Hg, arsenic and Pb) in maternal blood, fetal blood, and maternal hair.
Status | Recruiting |
Enrollment | 90 |
Est. completion date | December 2013 |
Est. primary completion date | September 2013 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 39 Years |
Eligibility |
Inclusion Criteria: Clinical diagnosis of preeclampsia (diagnosed per ACOG criteria) Exclusion Criteria: known chronic disease multipl pregnancies |
Observational Model: Ecologic or Community, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Turkey | Zekai Tahir Burak Education and Research Hospital | Ankara | |
Turkey | Zekai Tahir Burak Maternity Teaching Hospital | Ankara |
Lead Sponsor | Collaborator |
---|---|
Zekai Tahir Burak Women's Health Research and Education Hospital |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | increased levels of heavy metals in preeclamptic women | mercury, cadmium and lead levels in maternal blood and hair | 6 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04725812 -
Complement Regulation to Undo Systemic Harm in Preeclampsia
|
Phase 2 | |
Active, not recruiting |
NCT03744988 -
Serum Androgen Levels as a Marker for the Severity of Preeclampsia
|
||
Completed |
NCT02189148 -
First-trimester Prediction of Preeclampsia
|
||
Completed |
NCT04058405 -
Risk Prediction Models for Adverse Maternal and Neonatal Outcomes in Preeclampsia
|
||
Completed |
NCT03164304 -
Efficacy and Safety of 1 g Vs 2 g Per Hour Intravenous Maintenance Dose of MgSO4 in Women With Severe Pre-eclampsia
|
Phase 4 | |
Not yet recruiting |
NCT06265415 -
Comparative Study of Intravenous Labetalol Versus Intravenous Nitroglycerin Versus Sublingual Nifedipine
|
N/A | |
Completed |
NCT02379832 -
Pre-Eclampsia And Growth Restriction: a Longitudinal Study
|
||
Not yet recruiting |
NCT01538121 -
Antiphospholipid Antibodies and Early Severe Preeclampsia.
|
N/A | |
Recruiting |
NCT01382732 -
Carbetocin vs. Oxytocin for Prevention of Postpartum Bleeding in Patients With Severe Preeclampsia
|
Phase 3 | |
Completed |
NCT01408979 -
Effectiveness Study of Short Course of Magnesium Sulfate for Severe Preeclamsia
|
Phase 4 | |
Completed |
NCT01538147 -
Restless Leg Syndrome and Severe Preeclampsia
|
N/A | |
Terminated |
NCT03008616 -
Study of the Efficacy and Safety of AMAG-423 (Digoxin Immune Fab) in Antepartum Subjects With Severe Preeclampsia
|
Phase 2/Phase 3 |